advocacy in action: lack of consensus & the validity of progression-free survival
Published 13 years ago • 44 plays • Length 14:49Download video MP4
Download video MP3
Similar videos
-
8:58
improving the analyses of progression-free survival from clinical trials for novel cancer treatments
-
5:07
clifford a. hudis, md: the value of progression-free survival (pfs)
-
4:27
advocacy in action: cara tenenbaum - ovarian cancer national alliance
-
13:09
advocacy in action: international perspectives in cancer patient advocacy
-
11:12
advocacy in action: role of global advocate community in research & clinical trials
-
20:38
advocacy in action: value vs. cost in cancer care
-
13:52
advocacy in action: disparities & inequities in cancer care
-
2:54
advocacy in action: community oncology alliance (coa) public policy initiatives
-
3:30
comparing progression-free survival in the astris and sanovo trials
-
3:49
the impact of upfront ngs testing on overall outcomes
-
5:55
advocacy in action: cancer support community
-
3:19
advocacy in action | shatterproof
-
1:51
what does "overall survival" and "progression free survival" mean?
-
5:10
disease-free survival: endpoint for adjuvant therapy for cancer?
-
2:39
a look at overall survival data in cancer clinical trials
-
2:13
cf foundation | importance of advocacy
-
4:47
challenges in the development of cell-based therapies across asia